AP Biosciences
TWD129.50
0
+TWD2.50+1.97% 05:30 Today
Statistics
Day High
132
Day Low
123
52W High
236
52W Low
86.1
Volume
368,603
Avg. Volume
380,533
Mkt Cap
11.02B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-217.29MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company dedicated to the research and development of bispecific antibody drugs, aiming to fulfill critical unmet medical needs. Its robust pipeline features several promising candidates: Leading the pack, IBI302 is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration (nAMD). Further along, AP505 is undergoing Phase I clinical trials for various solid tumors. AP203, also in Phase I, is being investigated for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinomas. In earlier development, AP402 is currently in the pre-clinical research phase, focusing on breast cancer patients. Additionally, AP601 is also in pre-clinical research, targeting a broader spectrum of malignancies including lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. Founded in 2013, the company maintains its headquarters in Taipei City, Taiwan.
Show More
CEO
Jeng-Horng Her
Employees
37
Country
Taiwan
ISIN
TW0006945009
Listings
0 Comments
Share your thoughts
FAQs
What is AP Biosciences stock price today?▼
The current price of 6945.TWO is TWD129.50 TWD — it has increased by +1.97% in the past 24 hours. Watch AP Biosciences stock price performance more closely on the chart.
What is AP Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange AP Biosciences stocks are traded under the ticker 6945.TWO.
Is AP Biosciences stock price growing?▼
6945.TWO stock has fallen by -1.89% compared to the previous week, the month change is a -4.78% fall, over the last year AP Biosciences has showed a +13.1% increase.
What is AP Biosciences market cap?▼
Today AP Biosciences has the market capitalization of 11.02B
What is AP Biosciences revenue for the last year?▼
AP Biosciences revenue for the last year amounts to 0 TWD.
What is AP Biosciences net income for the last year?▼
6945.TWO net income for the last year is -217.29M TWD.
How many employees does AP Biosciences have?▼
As of November 3, 2026, the company has 37 employees.
In which sector is AP Biosciences located?▼
AP Biosciences operates in the Health & Wellness sector.
When did AP Biosciences complete a stock split?▼
AP Biosciences has not had any recent stock splits.
Where is AP Biosciences headquartered?▼
AP Biosciences is headquartered in Taipei City, Taiwan.